Communiqués Quest Diagnostics Incorporated

Actions

DGX

US74834L1008

Installations et services en soins de santé

Temps réel estimé 19:23:25 12/10/2026 Varia. 5j. Varia. 1 janv.
232,94 USD +0,85 % Graphique intraday de Quest Diagnostics Incorporated +0,26 % +34,17 %

Communiqués

01/10 Haystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials PR
22/09 Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026 PR
21/09 Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics PR
16/09 Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics PR
09/09 Apple Health app Users to be Able to Order Labs from Quest Diagnostics PR
31/08 GoodLife Health Bundles Quarterly ApoB Testing Into $299 Membership AQ
25/08 Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference PR
25/08 Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com PR
24/08 Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference PR
24/08 Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology PR
12/08 Quest Diagnostics Declares Quarterly Cash Dividend PR
30/07 Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics PR
23/07 Quest Diagnostics: Q2 Earnings Snapshot AQ
23/07 Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 PR
10/07 One in Five American Workers Tested Had a Positive Hair Drug Test in 2025, Signaling Persistent Long-Term Substance Use Patterns PR
08/07 Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI PR
01/07 United States Circuit Court Issues Positive Ruling For Fiduciaries And Adherence To Good Process AQ
24/06 Quest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residual Disease Testing PR
18/06 UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics PR
17/06 Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026 PR
16/06 Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report PR
19/05 Quest Diagnostics Declares Quarterly Cash Dividend PR
27/04 Quest Diagnostics Prices $500 Million of Senior Notes PR
21/04 Quest Diagnostics: Q1 Earnings Snapshot AQ
21/04 Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 PR
Aucun résultat pour cette recherche
🔇